journal article·2025-03-26

Quantum-Dot Ceramic Composites for Oxidative Stress Mitigation under Broad-Spectrum Radiation Exposure

Rajib Chandra Das, Marcela L. Chaki Borrás, Jung Ho Kim, Martin Carolan, Ronald Sluyter, Michael Lerch, Konstantin Konstantinov

ACS Applied Materials & Interfaces· Volume 17· Issue 12
Publisher page

Abstract

Nanomaterials offer a promising approach to mitigating radiation-induced oxidative stress by scavenging reactive oxygen species (ROS). However, developing a nanomaterial that provides protection across a wide range of radiation conditions is challenging due to the photoelectric effects linked to the atomic number ( Z ) of the materials. Quantum dots (QDs) in a composite system, owing to their small size and when used at low concentrations, minimize photoelectric effects and secondary electron generation. In this study, cerium oxide (CeO 2 ) QDs were combined with low- Z yttrium oxide (Y 2 O 3 ) to create a nanocomposite (NC) (henceforth CeO 2 QDs-Y 2 O 3 ) that exploits the synergistic effects of both materials, providing protection across a broader spectrum of radiation. CeO 2 QDs-Y 2 O 3 demonstrated superior ROS scavenging than individual CeO 2 and Y 2 O 3 under nonradiative conditions, particularly for hydroxyl radicals ( • OH) and hydrogen peroxide (H 2 O 2 ), two primary ROS generated under radiation. This improved performance, due to increased oxygen vacancies and a higher Ce 3+ /Ce 4+ ratio, indicates that these properties could help protect cells from oxidative stress during radiation exposure. Radioprotection analysis using the linear-quadratic (LQ) model revealed that the NC provided effective protection at both 150 kVp and 10 MV radiation energies. At 150 kVp, the obtained protection enhancement ratio (PER) values at 10% cell survival for CeO 2 QDs-Y 2 O 3, Y 2 O 3, and CeO 2 were 1.07, 1.16, and 0.89, respectively, suggesting that the radioprotection afforded by Y 2 O 3 in the NC outweighed the radiosensitization of the encrusted CeO 2 QDs. Additionally, despite the higher PER of Y 2 O 3, the NC displayed increased biocompatibility toward the human keratinocyte HaCaT cell line in the absence of radiation compared to Y 2 O 3 . At 10 MV, where photoelectric effects are minimal, the NC outperformed both individual components, yielding a PER of 1.28, or a 28% dose enhancement compared to 12% for Y 2 O 3 alone and 19% for CeO 2 . This study highlights the potential of CeO 2 QDs-Y 2 O 3 as a broad-spectrum radioprotective agent, offering enhanced biocompatibility and effective protection against radiation-induced oxidative stress across broad-ranging radiation conditions.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Luminescence Properties of Advanced Materials · Carbon and Quantum Dots Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute for Superconducting & Electronic Materials (ISEM), School of Physics, Faculty of Engineering and Information Sciences

University of Wollongong

Illawarra Cancer Care Centre

Wollongong Hospital

School of Chemistry and Molecular Bioscience, Faculty of Science, Medicine and Health

Molecular Horizons, Faculty of Science, Medicine and Health

Centre for Medical Radiation Physics (CMRP), Faculty of Engineering and Information Science

References (63)

Show source-provided references
1. 10.1056/NEJMra07214910.1056/NEJMra072149 ↗
2. 10.4065/mcp.2010.026010.4065/mcp.2010.0260 ↗
3. 10.7150/ijms.363510.7150/ijms.3635 ↗
4. 10.1007/s40572-024-00453-810.1007/s40572-024-00453-8 ↗
5. 10.3389/fnume.2023.122503410.3389/fnume.2023.1225034 ↗
6. 10.1016/j.jrras.2015.03.00310.1016/j.jrras.2015.03.003 ↗
7. Ayala, A.; Muñoz, M. F.; Argüelles, S. Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of and 4-Hydroxy-2-Nonenal Oxidative Medicine And Cellular Longevity, 2014. 2014 malondialdehyde.10.1155/2014/360438 ↗
8. 10.1080/0955300941455004110.1080/09553009414550041 ↗
9. Frei B. · 1997
10. 10.1155/2012/93648610.1155/2012/936486 ↗
11. 10.3389/fphys.2018.0047710.3389/fphys.2018.00477 ↗
12. 10.1161/01.HYP.37.2.55410.1161/01.HYP.37.2.554 ↗
13. 10.1080/1040869049046848910.1080/10408690490468489 ↗
14. 10.1016/j.cellsig.2007.04.00910.1016/j.cellsig.2007.04.009 ↗
15. 10.1155/2017/841676310.1155/2017/8416763 ↗
16. 10.1016/j.jcot.2018.08.01010.1016/j.jcot.2018.08.010 ↗
17. 10.1007/s12272-018-1083-610.1007/s12272-018-1083-6 ↗
18. 10.2307/357587810.2307/3575878 ↗
19. 10.1016/j.mtbio.2021.10012410.1016/j.mtbio.2021.100124 ↗
20. 10.1039/C8NR00325D10.1039/C8NR00325D ↗
21. 10.1103/PhysRevLett.85.344010.1103/PhysRevLett.85.3440 ↗
22. 10.1039/b615134e10.1039/b615134e ↗
23. 10.1016/j.nano.2008.10.00310.1016/j.nano.2008.10.003 ↗
24. 10.1021/nl052024f10.1021/nl052024f ↗
25. 10.1016/j.nano.2013.02.00810.1016/j.nano.2013.02.008 ↗
26. Attix F. H. · 2008
27. 10.1016/j.bbrc.2006.01.12910.1016/j.bbrc.2006.01.129 ↗
28. 10.1016/j.freeradbiomed.2014.07.01310.1016/j.freeradbiomed.2014.07.013 ↗
29. 10.1021/am301606910.1021/am3016069 ↗
30. 10.1016/j.matlet.2023.13452310.1016/j.matlet.2023.134523 ↗
31. 10.1039/D0TB00629G10.1039/D0TB00629G ↗
32. 10.1016/0024-3205(94)00925-210.1016/0024-3205(94)00925-2 ↗
33. 10.1083/jcb.106.3.76110.1083/jcb.106.3.761 ↗
34. 10.1021/acsami.0c1732610.1021/acsami.0c17326 ↗
35. 10.1515/raon-2015-004010.1515/raon-2015-0040 ↗
36. 10.1021/acs.jpcc.7b0664310.1021/acs.jpcc.7b06643 ↗
37. 10.3390/ma1321492810.3390/ma13214928 ↗
38. 10.1111/j.1151-2916.2002.tb00481.x10.1111/j.1151-2916.2002.tb00481.x ↗
39. 10.1016/j.materresbull.2010.02.00810.1016/j.materresbull.2010.02.008 ↗
40. 10.1007/s00339005146410.1007/s003390051464 ↗
41. 10.1063/1.514262110.1063/1.5142621 ↗
42. 10.1016/j.apsusc.2017.03.14510.1016/j.apsusc.2017.03.145 ↗
43. 10.1016/S0923-0467(96)03142-910.1016/S0923-0467(96)03142-9 ↗
44. 10.1021/cm061580n10.1021/cm061580n ↗
45. 10.1063/1.206187310.1063/1.2061873 ↗
46. 10.1016/j.ijhydene.2022.05.25510.1016/j.ijhydene.2022.05.255 ↗
47. 10.1021/am405196u10.1021/am405196u ↗
48. 10.1016/j.mtbio.2021.10012410.1016/j.mtbio.2021.100124 ↗
49. 10.1016/j.actbio.2016.12.01010.1016/j.actbio.2016.12.010 ↗
50. 10.1021/acs.langmuir.1c0205610.1021/acs.langmuir.1c02056 ↗
51. Martínez, R.; Poupard, M. F. N.; Alvarez, A.; Soprano, E.; Migliavacca, M.; Carrillo-Carrión, C.; Polo, E.; Pelaz, B.; Pino, P. D. In Nanoparticle Behavior and Stability in Biological Environments, 2020.10.1016/B978-0-12-816662-8.00002-3 ↗
52. 10.1016/j.canlet.2011.12.01210.1016/j.canlet.2011.12.012 ↗
53. 10.1166/jnn.2010.302810.1166/jnn.2010.3028 ↗
54. 10.1126/sciadv.aay975110.1126/sciadv.aay9751 ↗
55. 10.1002/adfm.20200469210.1002/adfm.202004692 ↗
56. 10.1021/es062563210.1021/es0625632 ↗
57. 10.2147/IJN.S9221810.2147/IJN.S92218 ↗
58. 10.1021/acsami.4c1148310.1021/acsami.4c11483 ↗
59. 10.1080/1091581060095954310.1080/10915810600959543 ↗
60. 10.1038/srep0001810.1038/srep00018 ↗
61. 10.1088/0031-9155/47/14/30510.1088/0031-9155/47/14/305 ↗
62. 10.1063/1.358936610.1063/1.3589366 ↗
63. 10.1038/s41598-019-55769-510.1038/s41598-019-55769-5 ↗